Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance.

    Olsson U, Egnell AC, Lee MR, Lundén GO, Lorentzon M, Salmivirta M, Bondjers G, Camejo G.

    Diabetes. 2001 Sep;50(9):2126-32.PMID: 11522680 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans.

    Rodriguéz-Lee M, Bondjers G, Camejo G.

    Curr Opin Lipidol. 2007 Oct;18(5):546-53. Review.PMID: 17885426 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.

    Rodríguez-Lee M, Ostergren-Lundén G, Wallin B, Moses J, Bondjers G, Camejo G.

    Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):130-5. Epub 2005 Oct 20.PMID: 16239593 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitus.

    Fioretto P, Keane WF, Kasiske BL, O'Donnell MP, Klein DJ.

    J Am Soc Nephrol. 1993 Apr;3(10):1694-704.PMID: 8318686 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats.

    Turcotte LP, Swenberger JR, Zavitz Tucker M, Yee AJ.

    Diabetes. 2001 Jun;50(6):1389-96.PMID: 11375340 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The extracellular matrix on atherogenesis and diabetes-associated vascular disease.

    Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G.

    Atheroscler Suppl. 2002 May;3(1):3-9. Review.PMID: 12044579 [PubMed - indexed for MEDLINE]Related articles

    8.

    Synthesis of sulphated proteoglycans by primary cultures of rat hepatocytes--modulation by matrix substratum.

    Santhosh A, Mathew S, Sudhakaran PR.

    Mol Cell Biochem. 1996 Dec 6;165(1):1-7.PMID: 8974075 [PubMed - indexed for MEDLINE]Related articles

    9.

    Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes.

    Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ.

    Acta Diabetol. 2005 Dec;42(4):162-70.PMID: 16382303 [PubMed - indexed for MEDLINE]Related articles

    10.

    Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.

    Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP.

    Diabetes. 2001 Nov;50(11):2481-6.PMID: 11679425 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.

    Xiao C, Watanabe T, Zhang Y, Trigatti B, Szeto L, Connelly PW, Marcovina S, Vaisar T, Heinecke JW, Lewis GF.

    Circ Res. 2008 Jul 18;103(2):159-66. Epub 2008 Jun 12.PMID: 18556574 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Proteoglycans synthesized by the hepatic granulomas isolated from schistosome-infected mice and by the granuloma-derived connective tissue cell lines.

    Silva LC, Borojevic R, Mourão PA.

    Biochim Biophys Acta. 1992 Jun 9;1139(1-2):96-104.PMID: 1610924 [PubMed - indexed for MEDLINE]Related articles

    13.

    AZ 242, a novel PPARalpha/gamma agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats.

    Ljung B, Bamberg K, Dahllöf B, Kjellstedt A, Oakes ND, Ostling J, Svensson L, Camejo G.

    J Lipid Res. 2002 Nov;43(11):1855-63.PMID: 12401884 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tesaglitazar, a dual PPAR{alpha}/{gamma} agonist, ameliorates glucose and lipid intolerance in obese Zucker rats.

    Oakes ND, Thalén P, Hultstrand T, Jacinto S, Camejo G, Wallin B, Ljung B.

    Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R938-46.PMID: 16183630 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.

    Julius U.

    Exp Clin Endocrinol Diabetes. 2003 Aug;111(5):246-50. Review.PMID: 12951628 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lipid mediators that modulate the extracellular matrix structure and function in vascular cells.

    Camejo G, Hurt-Camejo E, Olsson U, Bondjers G.

    Curr Atheroscler Rep. 1999 Sep;1(2):142-9. Review.PMID: 11122703 [PubMed - indexed for MEDLINE]Related articles

    19.

    Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.

    Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, Graham MJ, Crooke RM, Huang LS, Ginsberg HN.

    J Biol Chem. 2006 Dec 8;281(49):37603-15. Epub 2006 Sep 12.PMID: 16971390 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.

    Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ.

    J Appl Physiol. 2006 May;100(5):1467-74. Epub 2005 Dec 15.PMID: 16357064 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data